Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum | Zendy

Michael M. Tunney | Zendy; J. Payne | Zendy; Stephanie McGrath | Zendy; G.G. Einarsson | Zendy; Rebecca J. Ingram | Zendy; D.F. Gilpin | Zendy; V. Juarez-Perez | Zendy; J.S. Elborn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum

Author(s) -

Michael M. Tunney,

J. Payne,

Stephanie McGrath,

G.G. Einarsson,

Rebecca J. Ingram,

D.F. Gilpin,

V. Juarez-Perez,

J.S. Elborn

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky357

Subject(s) - sputum , pseudomonas aeruginosa , tobramycin , microbiology and biotechnology , cystic fibrosis , antimicrobial , antibiotics , medicine , chemistry , biology , bacteria , gentamicin , pathology , tuberculosis , genetics

To determine the antimicrobial activity of ALX-009, a combination of bovine lactoferrin and hypothiocyanite, in sputum against Pseudomonas aeruginosa and Burkholderia cepacia complex (Bcc), key pathogens causing infection in the lungs of cystic fibrosis (CF) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research